Area of research
Psychiatry and Mental health · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Epilepsy research and treatment, Bipolar Disorder and Treatment, Pharmacological Effects and Toxicity Studies, and Neuroscience and Neuropharmacology Research.
Prevalence, clinical features and prescription patterns of psychotropic medications for patients with psychotic depression in China
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open‐label extension of phase <scp>III</scp> randomized trials: Study 307
Prevalence and clinical features of atypical depression among patients with major depressive disorder in China
Adjunctive perampanel in adolescents with inadequately controlled partial‐onset seizures: A randomized study evaluating behavior, efficacy, and safety
Bipolar diagnosis in China: Evaluating diagnostic confidence using the Bipolarity Index
Prescribing patterns of psychotropic medications and clinical features in patients with major depressive disorder with and without comorbid dysthymia in China
Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study
Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures
Evaluation of Mood Disorder Questionnaire (MDQ) in Patients with Mood Disorders: A Multicenter Trial across China
Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in <scp>C</scp>hina
Adjunctive perampanel for refractory partial-onset seizures
Evaluation of adjunctive perampanel in patients with refractory partial‐onset seizures: Results of randomized global phase III study 305
Perampanel, a selective, noncompetitive α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial‐onset seizures: Interim results from phase III, extension study 307
Hypomanic symptoms assessed by the HCL-32 in patients with major depressive disorder: A multicenter trial across China
Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China